Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Ahern

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Breast Cancer Research and Treatment|February 28, 2014
Digoxin use and risk of invasive breast cancer: evidence from the Nurses' Health Study and meta-analysisThomas P Ahern, Rulla M Tamimi, Bernard A Rosner, et al.
Preventive Medicine|August 6, 2021
State-level rurality and cigarette smoking-associated cancer incidence and mortality: Do individual-level trends translate to population-level outcomes?Andrea C Villanti, Elias M Klemperer, Brian L Sprague, et al.
British Journal of Clinical Pharmacology|June 3, 2018
Use of antipsychotics and risk of breast cancer: a Danish nationwide case-control studyAnton Pottegård, Timothy L Lash, Deirdre Cronin-Fenton, et al.
Epidemiology (Cambridge, Mass.)|July 5, 2021
The Importance of Making Assumptions in Bias AnalysisRichard F MacLehose, Thomas P Ahern, Timothy L Lash, et al.
British Journal of Clinical Pharmacology|April 25, 2018
Cumulative exposure to phthalates from phthalate-containing drug products: a Danish population-wide studyZandra Nymand Ennis, Anne Broe, Anton Pottegård, et al.
Epidemiology (Cambridge, Mass.)|November 26, 2024
Parameterization of Beta Distributions for Bias Parameters of Binary Exposure Misclassification in Probabilistic Bias AnalysisQi Zhang, Richard F MacLehose, Lindsay J Collin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2024
CYP2D6 Phenotype and Breast Cancer Outcomes: A Bias Analysis and Meta-AnalysisRichard F MacLehose, Thomas P Ahern, Lindsay J Collin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 20, 2009
No increase in breast cancer recurrence with concurrent use of tamoxifen and some CYP2D6-inhibiting medicationsThomas P Ahern, Lars Pedersen, Deirdre P Cronin-Fenton, et al.
American Journal of Epidemiology|March 29, 2021
Lash et al. Respond to "Better Bias Analysis" and "Toward Better Bias Analysis"Timothy L Lash, Thomas P Ahern, Lindsay J Collin, et al.
JAMA Network Open|October 30, 2025
Postdiagnosis Statin Use and Breast Cancer MortalitySixten Harborg, Lars Pedersen, Henrik T Sørensen, et al.
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Breast Cancer Research and Treatment|February 28, 2014
Digoxin use and risk of invasive breast cancer: evidence from the Nurses' Health Study and meta-analysisThomas P Ahern, Rulla M Tamimi, Bernard A Rosner, et al.
Preventive Medicine|August 6, 2021
State-level rurality and cigarette smoking-associated cancer incidence and mortality: Do individual-level trends translate to population-level outcomes?Andrea C Villanti, Elias M Klemperer, Brian L Sprague, et al.
British Journal of Clinical Pharmacology|June 3, 2018
Use of antipsychotics and risk of breast cancer: a Danish nationwide case-control studyAnton Pottegård, Timothy L Lash, Deirdre Cronin-Fenton, et al.
Epidemiology (Cambridge, Mass.)|July 5, 2021
The Importance of Making Assumptions in Bias AnalysisRichard F MacLehose, Thomas P Ahern, Timothy L Lash, et al.
British Journal of Clinical Pharmacology|April 25, 2018
Cumulative exposure to phthalates from phthalate-containing drug products: a Danish population-wide studyZandra Nymand Ennis, Anne Broe, Anton Pottegård, et al.
Epidemiology (Cambridge, Mass.)|November 26, 2024
Parameterization of Beta Distributions for Bias Parameters of Binary Exposure Misclassification in Probabilistic Bias AnalysisQi Zhang, Richard F MacLehose, Lindsay J Collin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2024
CYP2D6 Phenotype and Breast Cancer Outcomes: A Bias Analysis and Meta-AnalysisRichard F MacLehose, Thomas P Ahern, Lindsay J Collin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 20, 2009
No increase in breast cancer recurrence with concurrent use of tamoxifen and some CYP2D6-inhibiting medicationsThomas P Ahern, Lars Pedersen, Deirdre P Cronin-Fenton, et al.
American Journal of Epidemiology|March 29, 2021
Lash et al. Respond to "Better Bias Analysis" and "Toward Better Bias Analysis"Timothy L Lash, Thomas P Ahern, Lindsay J Collin, et al.
JAMA Network Open|October 30, 2025
Postdiagnosis Statin Use and Breast Cancer MortalitySixten Harborg, Lars Pedersen, Henrik T Sørensen, et al.
Pageof 11